Physician profile
Fanny Berg
NPI 1720182256
$2,591.50
in general payments reported to CMS, 2019-2025
23 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,965 · 2020: $472 · 2022: $155.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $492.84 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $228.59 | 2019 | |
| Pfizer INC. | $211.24 | 2019-2020 | |
| Lilly USA, LLC | $208.70 | 2019-2020 | |
| Amgen INC. | $179.29 | 2019-2020 | |
| Ucb, INC. | $167.20 | 2019-2020 | |
| Bard Peripheral Vascular, INC. | $154.51 | 2022 | |
| Celgene Corporation | $152.46 | 2019 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $129.14 | 2019-2020 | |
| Leo Pharma INC. | $111.40 | 2019-2020 | |
| Janssen Biotech, INC. | $110.87 | 2019 | |
| Sun Pharmaceutical Industries INC. | $91.99 | 2019-2020 | |
| Galderma Laboratories, L.P. | $65.23 | 2019-2020 | |
| Regeneron Healthcare Solutions, INC. | $55.08 | 2020 | |
| Genzyme Corporation | $48.64 | 2019-2020 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Prugen, INC. Pharmaceuticals | $44.24 | 2019 | |
| Vyne Pharmaceuticals INC. | $35.74 | 2020 | |
| Almirall LLC | $19.66 | 2019 | |
| Allergan, INC. | $18.55 | 2019 | |
| Merck Sharp & Dohme LLC | $17.62 | 2019 | |
| Biofrontera INC. | $16.37 | 2019 | |
| Sanofi-Aventis U.S. LLC | $16.17 | 2019 | |
| Sientra, INC. | $15.97 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Fanny Berg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.